Abiopharma

Nanox Announces Second Quarter of 2025 Financial Resultsand Provides Business Update

New Form 10-Q - Monopar Therapeutics Filed: 2025-08-12 AccNo: 0001437749-25-026042 Size: 5 MB

New Form SC TO-T - DURECT CORP Filed: 2025-08-12 AccNo: 0001193125-25-178491 Size: 1 MB

Ecolab Inc. - Ecolab to Acquire Ovivo’s Electronics Ultra-Pure Water Business

New Form 8-K - MIRA PHARMACEUTICALS, INC. Filed: 2025-08-12 AccNo: 0001641172-25-023110 Size: 212 KB Item 8.01: Other Events

New Form 8-K - Grace Therapeutics, Inc. Filed: 2025-08-12 AccNo: 0001140361-25-030400 Size: 322 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Taysha Gene Therapies Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Ginkgo Automation Appoints Brian OSullivan as Head of Commercial to Accelerate External Growth

Financial Statements and Related Announcement: Half Yearly Results

ProPhase Labs Announces Full USPTO Approval for Issuance of U.S. Patent Protecting Esophageal Adenocarcinoma Risk Assessment

IM Cannabis Reports Second Quarter 2025 Financial Results

Monopar Therapeutics ReportsSecond Quarter 2025 Financial Results and Recent Developments

PolyPid Appoints Dr. Nurit Tweezer-Zaks as Chief Medical Officer

180 Life Sciences (ETHZilla) Holds 82,186 ETH

electroCore Names Kelly Benning, Accomplished Healthcare Executive, as SVP of Truvaga